CORTI STRENGTHENS LEADERSHIP TEAM WITH STRATEGIC SENIOR HIRES FROM MICROSOFT AND PHILIPS

September 12, 2024 01:20 AM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

The move comes as Corti doubles down on its mission to transform overburdened healthcare systems with accessible and trustworthy AI

NEW YORK, Sept. 11, 2024 /PRNewswire/ -- Corti, the global AI engine designed for healthcare, is bolstering its leadership team with the addition of three more senior executives. The strategic move furthers the company's mission of helping billions of people benefit from low risk, high quality care through its safe and effective Generative AI, woven into the fabric of every patient interaction around the world.

Following a period of rapid growth for the business - which had processed more than 100 million patient interactions - Corti is now welcoming new talent from some of the world's biggest organisations to help continue its expansion.

Chad Compton joins Corti as Chief Revenue Officer from Microsoft's leadership team. Prior to Microsoft, Chad was a key executive at Nuance, which was acquired by Microsoft in 2022 for $19.7 billion. At Nuance, he oversaw one of the world's most successful healthcare partnership sales teams, generating hundreds of millions of dollars in revenue. In his new role at Corti, Chad will leverage his extensive experience to drive growth across the global market.

Frederik Brabant, MD will step into the role of Chief Medical Strategy Officer. Previously, Frederik served as the chief medical information officer and VP of international healthcare partnerships at Microsoft Nuance. With nearly a decade of leadership experience at Nuance, Frederik played a pivotal role in driving the success of flagship products such as Dragon Dictation and leading global partnership initiatives worth over millions. His role at Corti will be instrumental in shaping the company's medical strategy and expanding its global footprint.

Yvonne Kirsch is Corti's new VP Partnerships, North America, coming from Philips Speech, where she was running the North American Unit. Yvonne's experience in building strategic partnerships and driving business growth will power Corti's next chapter in the region, where Corti is on track to process more than 100 million patient interactions annually by 2025.

These three new additions to the Corti team builds on a series of other recent hires from Microsoft Nuance and Philips Speech, including Milko Jovanoski, now VP of partnerships for Europe, and Robert Lamprell, UK commercial director, who previously held positions as international marketing director and senior account director at Microsoft Nuance, respectively. Last week, Mikaël Grynszpan also joined the Corti team from Philips Speech as Director of Sales in France, following in the footsteps of Yvonne Kirsch and Corti's CPO, Florian Schwieker, who also made the move from Philips Speech to Corti.

Speaking about the new hires, Andreas Cleve, co-founder and CEO of Corti, said: "These critical hires mark a significant milestone for Corti as we continue to scale our impact across healthcare. When top commercial talent moves from such major companies to the promising new incumbent, it marks the start of a new era. Welcoming such unparalleled expertise to the team will be invaluable as we continue to innovate and expand our global reach, clearing the path for billions of patients around the world to enjoy low risk, high quality care."

Corti is transforming healthcare by integrating advanced, purpose-built AI into every patient interaction. Its AI seamlessly integrates into virtually any platform, and unlike other co-pilots, it actively supports healthcare professionals by providing real-time prompts, enhancing decision-making throughout their time with patients. It also automates and enhances workflows by removing the need for time-consuming, manual note taking and medical coding - significantly reducing administrative burdens and minimising errors by up to 40 percent.

Setting it apart from other AI models built on open-source data, Corti's platform is backed by eight years of research and uses rigorously verified healthcare data, making it the most trustworthy AI support tool available. Processing over 100 million patient interactions every year, Corti is proving to be an indispensable, global asset in delivering high-quality, personalised care.

Chad Compton, Chief Revenue Officer at Corti, added: "I'm thrilled to join Corti at such a pivotal moment in the future of healthcare. We're already powering millions of patient interactions every year, and this is just the beginning. Corti is redefining how AI can enhance every corner of healthcare by delivering trusted, real-time support in every patient encounter. Our mission to expand Corti's high-quality AI technology to more healthcare providers worldwide addresses an urgent need, and I am excited to be a part of driving this change."

Frederik Brabant, Chief Medical Strategy Officer at Corti, said: "After years of treating individual patients, I realised I could improve the lives of millions if I scaled my efforts beyond the bedside. By reducing administrative burden through safe and effective AI, Corti is relieving healthcare professionals of the immense pressure I once experienced as a physician. I'm looking forward to being part of a team allowing healthcare professionals like me to focus on what truly matters - caring for patients."

Yvonne Kirsch, Corti's VP Partnerships North America, said: "Joining Corti in North America amid our exponential growth in the US has been momentous. More providers are seeing the immense potential of Corti's AI - not just for their bottom line, but for easing burnout among overburdened healthcare professionals. Feedback has been overwhelmingly positive, and I'm excited to bring on more strategic partners to extend this technology to thousands more who need it."

For more information, please visit: www.corti.ai

About Corti

Founded in 2016 by Lars Maaløe and Andreas Cleve, Corti is a healthcare AI research company dedicated to developing a safe and effective Generative AI platform tailored to healthcare's unique needs. Having learned from more than 100 million patient interactions, Corti's AI minimizes paperwork and errors across the patient journey, offering expert guidance and support.

Corti's AI not only takes notes but also quality assures, journals, codes, nudges, prompts, and documents every patient interaction. This reduces the margin for error by up to 40 percent and administrative time by up to 80 percent. With significant research findings in speech processing, dialectic challenges, medical coding, and language understanding, Corti's artificial intelligence enhances real-time consultations across the entire patient journey across the United States and Europe.

Press Contact
Inkhouse for Corti
[email protected]  


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.